Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Autoimmune Disorders

  Free Subscription


Articles published in J Autoimmun

Retrieve available abstracts of 131 articles:
HTML format



Single Articles


    November 2022
  1. SHARFE N, Dalal I, Naghdi Z, Lefaudeux D, et al
    NFkappaB pathway dysregulation due to reduced RelB expression leads to severe autoimmune disorders and declining immunity.
    J Autoimmun. 2022 Nov 16:102946. doi: 10.1016/j.jaut.2022.102946.
    PubMed     Abstract available


  2. WILDNER G
    Antigenic mimicry - The key to autoimmunity in immune privileged organs.
    J Autoimmun. 2022 Nov 7:102942. doi: 10.1016/j.jaut.2022.102942.
    PubMed     Abstract available


  3. CHENG Z, Hou G, Shen N
    Evolving understandings for the roles of non-coding RNAs in autoimmunity and autoimmune disease.
    J Autoimmun. 2022 Nov 7:102948. doi: 10.1016/j.jaut.2022.102948.
    PubMed     Abstract available


  4. LIU Q, Zheng Y, Goronzy JJ, Weyand CM, et al
    T cell aging as a risk factor for autoimmunity.
    J Autoimmun. 2022 Nov 7:102947. doi: 10.1016/j.jaut.2022.102947.
    PubMed     Abstract available


  5. BERRYMAN MA, Milletich PL, Petrone JR, Roesch LF, et al
    Autoimmune-associated genetics impact probiotic colonization of the infant gut.
    J Autoimmun. 2022;133:102943.
    PubMed     Abstract available


  6. MEHLSEN J, Brinth L, Pors K, Varming K, et al
    Autoimmunity in patients reporting long-term complications after exposure to human papilloma virus vaccination.
    J Autoimmun. 2022;133:102921.
    PubMed    


    October 2022
  7. ZENG L, Yang K, Zhang T, Zhu X, et al
    Research progress of single-cell transcriptome sequencing in autoimmune diseases and autoinflammatory disease: A review.
    J Autoimmun. 2022;133:102919.
    PubMed     Abstract available


  8. GERUSSI A, Soskic B, Asselta R, Invernizzi P, et al
    GWAS and autoimmunity: What have we learned and what next.
    J Autoimmun. 2022;133:102922.
    PubMed     Abstract available


  9. HAKROUSH S, Tampe D, Baier E, Kluge IA, et al
    Intrarenal synthesis of complement C3 localized to distinct vascular compartments in ANCA-associated renal vasculitis.
    J Autoimmun. 2022;133:102924.
    PubMed     Abstract available


  10. MIZRACHI M, Anderson E, Carroll KR, Tehrani N, et al
    Cognitive dysfunction in SLE: An understudied clinical manifestation.
    J Autoimmun. 2022;132:102911.
    PubMed     Abstract available


  11. BAKHTIAR S, Kaffenberger C, Salzmann-Manrique E, Donhauser S, et al
    Regulatory B cells in patients suffering from inborn errors of immunity with severe immune dysregulation.
    J Autoimmun. 2022;132:102891.
    PubMed     Abstract available


  12. BRUSCHI M, Angeletti A, Kajana X, Moroni G, et al
    Evidence for charge-based mimicry in anti dsDNA antibody generation.
    J Autoimmun. 2022;132:102900.
    PubMed     Abstract available


  13. MAZ MP, Martens JWS, Hannoudi A, Reddy AL, et al
    Recent advances in cutaneous lupus.
    J Autoimmun. 2022;132:102865.
    PubMed     Abstract available


  14. ARINGER M, Costenbader K, Dorner T, Johnson SR, et al
    Advances in SLE classification criteria.
    J Autoimmun. 2022;132:102845.
    PubMed     Abstract available


    September 2022
  15. SJOGREN T, Bratland E, Royrvik EC, Grytaas MA, et al
    Screening patients with autoimmune endocrine disorders for cytokine autoantibodies reveals monogenic immune deficiencies.
    J Autoimmun. 2022;133:102917.
    PubMed     Abstract available


  16. AENDEKERK JP, Jiemy WF, Raveling-Eelsing E, Bijnens N, et al
    CD163 and CD206 expression define distinct macrophage subsets involved in active ANCA-associated glomerulonephritis.
    J Autoimmun. 2022;133:102914.
    PubMed     Abstract available


  17. BAKER KF, Skelton AJ, Lendrem DW, Scadeng A, et al
    Erratum to "Predicting drug-free remission in rheumatoid arthritis: A prospective interventional cohort study" [J. Autoimmun. 105 (December 2019) 102298].
    J Autoimmun. 2022 Sep 19:102913. doi: 10.1016/j.jaut.2022.102913.
    PubMed    


  18. AZOULAY LD, Pineton de Chambrun M, Larcher R, Pene F, et al
    Prevalence, characteristics and outcome of cardiac manifestations in critically-ill antiphospholipid syndrome patients.
    J Autoimmun. 2022;133:102908.
    PubMed     Abstract available


  19. SCHOLZ GA, Fux M, Christ L, Iype J, et al
    Divergent regulatory T cell responses to high-dose methylprednisolone and tocilizumab in giant cell arteritis.
    J Autoimmun. 2022;133:102909.
    PubMed    


  20. ALVAREZ D, Rua C, Velasquez Berrio M, Catano JU, et al
    Extracellular vesicles released upon stimulation with antiphospholipid antibodies: An actual direct procoagulant mechanism or a new factor in the lupus anticoagulant paradox?
    J Autoimmun. 2022;133:102905.
    PubMed     Abstract available


  21. LI X, Zhang Y, Wang J, Li Y, et al
    zVAD alleviates experimental autoimmune hepatitis in mice by increasing the sensitivity of macrophage to TNFR1-dependent necroptosis.
    J Autoimmun. 2022;133:102904.
    PubMed     Abstract available


  22. SAKURABA K, Krishnamurthy A, Sun J, Zheng X, et al
    Autoantibodies targeting malondialdehyde-modifications in rheumatoid arthritis regulate osteoclasts via inducing glycolysis and lipid biosynthesis.
    J Autoimmun. 2022;133:102903.
    PubMed     Abstract available


  23. EFE C, Tascilar K, Gerussi A, Bolis F, et al
    SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis.
    J Autoimmun. 2022;132:102906.
    PubMed     Abstract available


    August 2022
  24. CHEN K, Li Y, Yang H
    Poor responses and adverse outcomes of myasthenia gravis after thymectomy: Predicting factors and immunological implications.
    J Autoimmun. 2022;132:102895.
    PubMed     Abstract available


  25. XIA Y, Jiang C, Yang M, Liu T, et al
    SB431542 alleviates lupus nephritis by regulating B cells and inhibiting the TLR9/TGFbeta1/PDGFB signaling.
    J Autoimmun. 2022;132:102894.
    PubMed     Abstract available


  26. RODRIGUEZ Y, Rojas M, Beltran S, Polo F, et al
    Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review.
    J Autoimmun. 2022;132:102898.
    PubMed     Abstract available


  27. JIANING W, Jingyi X, Pingting Y
    Neuropsychiatric lupus erythematosus: Focusing on autoantibodies.
    J Autoimmun. 2022 Aug 24:102892. doi: 10.1016/j.jaut.2022.102892.
    PubMed     Abstract available


  28. JIANG Y, Cheng Y, Ma S, Li T, et al
    Systemic lupus erythematosus-complicating immune thrombocytopenia: From pathogenesis to treatment.
    J Autoimmun. 2022 Aug 24:102887. doi: 10.1016/j.jaut.2022.102887.
    PubMed     Abstract available


  29. ZHANG W, Shao T, Leung PSC, Tsuneyama K, et al
    Dual B-cell targeting therapy ameliorates autoimmune cholangitis.
    J Autoimmun. 2022;132:102897.
    PubMed     Abstract available


  30. MYHR KA, Zinglersen AH, Hermansen MF, Jepsen MM, et al
    Left ventricular size and function in patients with systemic lupus erythematosus associate with lupus anticoagulant: An echocardiographic follow-up study.
    J Autoimmun. 2022;132:102884.
    PubMed     Abstract available


  31. BEVILACQUA ROLFSEN FERREIRA DA, Pereira das Neves S, Roque Oliveira SC, Marques F, et al
    Comparative effectiveness of preventive treatment with dimethyl fumarate-loaded solid lipid nanoparticles and oral dimethyl fumarate in a mouse model of multiple sclerosis.
    J Autoimmun. 2022;132:102893.
    PubMed     Abstract available


  32. YU C, Li P, Dang X, Zhang X, et al
    Lupus nephritis: new progress in diagnosis and treatment.
    J Autoimmun. 2022 Aug 20:102871. doi: 10.1016/j.jaut.2022.102871.
    PubMed     Abstract available


  33. NING W, Xu W, Cong X, Fan H, et al
    COVID-19 mRNA vaccine BNT162b2 induces autoantibodies against type I interferons in a healthy woman.
    J Autoimmun. 2022;132:102896.
    PubMed     Abstract available


  34. REILY C, Rice T, Crossman DK, Rizk DV, et al
    Phosphatase control of cytokine-mediated overproduction of galactose-deficient IgA1, the main autoantigen in IgA nephropathy.
    J Autoimmun. 2022;132:102883.
    PubMed     Abstract available


  35. ROUSSELIN C, Amoura Z, Faguer S, Bataille P, et al
    Renal and vascular outcomes in patients with isolated antiphospholipid syndrome nephropathy.
    J Autoimmun. 2022;132:102889.
    PubMed     Abstract available


  36. XU Y, Li P, Li K, Li N, et al
    Pathological mechanisms and crosstalk among different forms of cell death in systemic lupus erythematosus.
    J Autoimmun. 2022 Aug 10:102890. doi: 10.1016/j.jaut.2022.102890.
    PubMed     Abstract available


  37. ARBITMAN L, Furie R, Vashistha H
    B cell-targeted therapies in systemic lupus erythematosus.
    J Autoimmun. 2022 Aug 10:102873. doi: 10.1016/j.jaut.2022.102873.
    PubMed     Abstract available


  38. IZAGIRRE A, Arzallus T, Garmendia M, Torrente S, et al
    Autoimmune hepatitis following COVID-19 vaccination.
    J Autoimmun. 2022;132:102874.
    PubMed    


  39. SIDDIQI KZ, Zinglersen AH, Iversen KK, Rasmussen NS, et al
    A cluster of type II interferon-regulated genes associates with disease activity in patients with systemic lupus erythematosus.
    J Autoimmun. 2022;132:102869.
    PubMed     Abstract available


  40. CHEN Y, Lin J, Xiao L, Zhang X, et al
    Gut microbiota in systemic lupus erythematosus: A fuse and a solution.
    J Autoimmun. 2022;132:102867.
    PubMed     Abstract available


    July 2022
  41. TAN Y, Yang S, Liu Q, Li Z, et al
    Pregnancy-related complications in systemic lupus erythematosus.
    J Autoimmun. 2022 Jul 21:102864. doi: 10.1016/j.jaut.2022.102864.
    PubMed     Abstract available


  42. LOU H, Ling GS, Cao X
    Autoantibodies in systemic lupus erythematosus: From immunopathology to therapeutic target.
    J Autoimmun. 2022 Jul 21:102861. doi: 10.1016/j.jaut.2022.102861.
    PubMed     Abstract available


  43. LI H, Boulougoura A, Endo Y, Tsokos GC, et al
    Abnormalities of T cells in systemic lupus erythematosus: new insights in pathogenesis and therapeutic strategies.
    J Autoimmun. 2022 Jul 21:102870. doi: 10.1016/j.jaut.2022.102870.
    PubMed     Abstract available


  44. VIEIRA M, Comarmond C, Labreuche J, Mirouse A, et al
    COVID-19 outcomes in giant cell arteritis and polymyalgia rheumatica versus rheumatoid arthritis: A national, multicenter, cohort study.
    J Autoimmun. 2022;132:102868.
    PubMed     Abstract available


  45. LIU Y, Yu X, Zhang W, Zhang X, et al
    Mechanistic insight into premature atherosclerosis and cardiovascular complications in systemic lupus erythematosus.
    J Autoimmun. 2022 Jul 16:102863. doi: 10.1016/j.jaut.2022.102863.
    PubMed     Abstract available


  46. FERRI C, Gragnani L, Raimondo V, Visentini M, et al
    Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases.
    J Autoimmun. 2022;131:102866.
    PubMed     Abstract available


  47. NING W, Cheng D, Howe PH, Bian C, et al
    Staphylococcus aureus peptidoglycan (PGN) induces pathogenic autoantibody production via autoreactive B cell receptor clonal selection, implications in systemic lupus erythematosus.
    J Autoimmun. 2022;131:102860.
    PubMed     Abstract available


  48. HUANG C, Yi P, Zhu M, Zhou W, et al
    Erratum to "Safety and efficacy of fecal microbiota transplantation for treatment of systemic lupus erythematosus: An EXPLORER trial" [J. Autoimmun. 130, June 2022, 102844].
    J Autoimmun. 2022;131:102862.
    PubMed    


  49. NATARAJA C, Flynn J, Dankers W, Northcott M, et al
    GILZ regulates type I interferon release and sequesters STAT1.
    J Autoimmun. 2022;131:102858.
    PubMed     Abstract available


  50. IYER VS, Boddul SV, Johnsson AK, Raposo B, et al
    Modulating T-cell activation with antisense oligonucleotides targeting lymphocyte cytosolic protein 2.
    J Autoimmun. 2022;131:102857.
    PubMed     Abstract available


    June 2022
  51. LIU J, Zhang X, Cao X
    Dendritic cells in systemic lupus erythematosus: From pathogenesis to therapeutic applications.
    J Autoimmun. 2022 Jun 27:102856. doi: 10.1016/j.jaut.2022.102856.
    PubMed     Abstract available


  52. BAKASIS AD, Mavragani CP, Voulgari PV, Gerolymatou N, et al
    COVID-19: Clinical features and outcomes in unvaccinated 2-dose and 3-dose vaccinated against SARS-CoV-2 patients with systemic autoimmune and autoinflammatory rheumatic diseases.
    J Autoimmun. 2022;131:102846.
    PubMed     Abstract available


  53. HUANG C, Yi P, Zhu M, Zhou W, et al
    Safety and efficacy of fecal microbiota transplantation for treatment of systemic lupus erythematosus: An EXPLORER trial.
    J Autoimmun. 2022 Jun 8:102844. doi: 10.1016/j.jaut.2022.102844.
    PubMed     Abstract available


  54. WANG C, Zhou W, Liu Y, Xu Y, et al
    Nuclear translocation of RIG-I promotes cellular apoptosis.
    J Autoimmun. 2022;130:102840.
    PubMed     Abstract available


    May 2022
  55. BUCCI T, Ames PR, Cammisotto V, Bartimoccia S, et al
    Proprotein convertase subtilisin/kexin type 9 (PCSK9) levels in primary antiphospholipid syndrome. The multicenter ATHERO-APS study.
    J Autoimmun. 2022;129:102832.
    PubMed     Abstract available


  56. FAN NW, Wang S, Ortiz G, Chauhan SK, et al
    Autoreactive memory Th17 cells are principally derived from T-bet(+)RORgammat(+) Th17/1 effectors.
    J Autoimmun. 2022;129:102816.
    PubMed     Abstract available


    April 2022
  57. MELDERIS S, Warkotsch MT, Dang J, Hagenstein J, et al
    The Amphiregulin/EGFR axis protects from lupus nephritis via downregulation of pathogenic CD4(+) T helper cell responses.
    J Autoimmun. 2022;129:102829.
    PubMed     Abstract available


  58. COUTANT F, Bachet R, Pin JJ, Alonzo M, et al
    Monoclonal antibodies from B cells of patients with anti-MDA5 antibody-positive dermatomyositis directly stimulate interferon gamma production.
    J Autoimmun. 2022;130:102831.
    PubMed     Abstract available


  59. LI X, Gao L, Tong X, Chan VKY, et al
    Autoimmune conditions following mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccination: A descriptive cohort study among 1.1 million vaccinated people in Hong Kong.
    J Autoimmun. 2022;130:102830.
    PubMed     Abstract available


    March 2022
  60. ZHAO Z, Zhu H, Li Q, Liao W, et al
    Skin CD4(+) Trm cells distinguish acute cutaneous lupus erythematosus from localized discoid lupus erythematosus/subacute cutaneous lupus erythematosus and other skin diseases.
    J Autoimmun. 2022;128:102811.
    PubMed     Abstract available


  61. CENTA M, Weinstein EG, Clemente JC, Faith JJ, et al
    Impaired central tolerance induces changes in the gut microbiota that exacerbate autoimmune hepatitis.
    J Autoimmun. 2022;128:102808.
    PubMed     Abstract available


  62. TEKTONIDOU MG
    Cardiovascular disease risk in antiphospholipid syndrome: Thrombo-inflammation and atherothrombosis.
    J Autoimmun. 2022;128:102813.
    PubMed     Abstract available


    February 2022
  63. BOSTAN H, Ucan B, Kizilgul M, Calapkulu M, et al
    Relapsed and newly diagnosed Graves' disease due to immunization against COVID-19: A case series and review of the literature.
    J Autoimmun. 2022;128:102809.
    PubMed     Abstract available


  64. TIAN J, Zhou H, Fang D, Yi P, et al
    The global burden of heterogeneity of lupus erythematosus interventional trials.
    J Autoimmun. 2022;128:102798.
    PubMed     Abstract available


  65. OHTO T, Tayeh AA, Nishikomori R, Abe H, et al
    Intracellular virus sensor MDA5 mutation develops autoimmune myocarditis and nephritis.
    J Autoimmun. 2022;127:102794.
    PubMed     Abstract available


  66. ARASE N, Tsuji H, Takamatsu H, Jin H, et al
    Corrigendum to "Cell surface-expressed Ro52/IgG/HLA-DR complex is targeted by autoantibodies in patients with inflammatory myopathies" [J. Autoimmun. 126 (2022) 102774].
    J Autoimmun. 2022 Feb 9:102797. doi: 10.1016/j.jaut.2022.102797.
    PubMed    


  67. VIEIRA M, Regnier P, Maciejewski-Duval A, Le Joncour A, et al
    Interferon signature in giant cell arteritis aortitis.
    J Autoimmun. 2022;127:102796.
    PubMed     Abstract available


    January 2022
  68. HANSEN CHF, Larsen CS, Zachariassen LF, Mentzel CMJ, et al
    Gluten-free diet reduces autoimmune diabetes mellitus in mice across multiple generations in a microbiota-independent manner.
    J Autoimmun. 2022;127:102795.
    PubMed     Abstract available


  69. PASSAM FH, Chen G, Chen VM, Qi M, et al
    Betaeta-2-glycoprotein I exerts antithrombotic function through its domain V in mice.
    J Autoimmun. 2022;126:102747.
    PubMed     Abstract available


    December 2021
  70. AFRASIABI A, Keane JT, Ong LTC, Alinejad-Rokny H, et al
    Genetic and transcriptomic analyses support a switch to lytic phase in Epstein Barr virus infection as an important driver in developing Systemic Lupus Erythematosus.
    J Autoimmun. 2021;127:102781.
    PubMed     Abstract available


  71. ROJAS M, Ramirez-Santana C, Acosta-Ampudia Y, Monsalve DM, et al
    New insights into the taxonomy of autoimmune diseases based on polyautoimmunity.
    J Autoimmun. 2021;126:102780.
    PubMed     Abstract available


  72. ARASE N, Tsuji H, Takamatsu H, Jin H, et al
    Cell surface-expressed Ro52/IgG/HLA-DR complex is targeted by autoantibodies in patients with inflammatory myopathies.
    J Autoimmun. 2021;126:102774.
    PubMed     Abstract available


  73. MAHROUM N, Alghory A, Kiyak Z, Alwani A, et al
    Ferritin - from iron, through inflammation and autoimmunity, to COVID-19.
    J Autoimmun. 2021;126:102778.
    PubMed     Abstract available


  74. RAIKER R, Pakhchanian H, DeYoung C, Gupta L, et al
    Short term outcomes of COVID-19 in lupus: Propensity score matched analysis from a nationwide multi-centric research network.
    J Autoimmun. 2021;125:102730.
    PubMed     Abstract available


    November 2021
  75. AVCI E, Abasiyanik F
    Autoimmune hepatitis after SARS-CoV-2 vaccine: New-onset or flare-up?
    J Autoimmun. 2021;125:102745.
    PubMed     Abstract available


  76. FERRI C, Ursini F, Gragnani L, Raimondo V, et al
    Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups.
    J Autoimmun. 2021;125:102744.
    PubMed     Abstract available


  77. PADOAN R, Gatto M, Ghirardello A, Tonello M, et al
    IgG anti-Pentraxin 3 antibodies are a novel biomarker of ANCA-associated vasculitis and better identify patients with eosinophilic granulomatosis with polyangiitis.
    J Autoimmun. 2021;124:102725.
    PubMed     Abstract available


    October 2021
  78. TZIOUFAS AG, Bakasis AD, Goules AV, Bitzogli K, et al
    A prospective multicenter study assessing humoral immunogenicity and safety of the mRNA SARS-CoV-2 vaccines in Greek patients with systemic autoimmune and autoinflammatory rheumatic diseases.
    J Autoimmun. 2021;125:102743.
    PubMed     Abstract available


  79. HANSEN N, Krasiuk I, Titsch T
    Neural autoantibodies in delirium.
    J Autoimmun. 2021;125:102740.
    PubMed     Abstract available


  80. GARRIDO I, Lopes S, Simoes MS, Liberal R, et al
    Autoimmune hepatitis after COVID-19 vaccine - more than a coincidence.
    J Autoimmun. 2021;125:102741.
    PubMed     Abstract available


  81. PATRIZIO A, Ferrari SM, Antonelli A, Fallahi P, et al
    A case of Graves' disease and type 1 diabetes mellitus following SARS-CoV-2 vaccination.
    J Autoimmun. 2021;125:102738.
    PubMed     Abstract available


    September 2021
  82. GATTO M, Saccon F, Andreoli L, Bartoloni E, et al
    Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort.
    J Autoimmun. 2021;124:102729.
    PubMed     Abstract available


  83. RELA M, Jothimani D, Vij M, Rajakumar A, et al
    Auto-immune hepatitis following COVID vaccination.
    J Autoimmun. 2021;123:102688.
    PubMed     Abstract available


  84. BOGIE JFJ, Vanmierlo T, Vanmol J, Timmermans S, et al
    Liver X receptor beta deficiency attenuates autoimmune-associated neuroinflammation in a T cell-dependent manner.
    J Autoimmun. 2021;124:102723.
    PubMed     Abstract available


  85. SALVIANO-SILVA A, Becker M, Augusto DG, Busch H, et al
    Genetic association and differential expression of HLAComplexGroup lncRNAs in pemphigus.
    J Autoimmun. 2021;123:102705.
    PubMed     Abstract available


  86. VALENTINE KM, Mullins GN, Davalos OA, Seow LW, et al
    CD8 follicular T cells localize throughout the follicle during germinal center reactions and maintain cytolytic and helper properties.
    J Autoimmun. 2021;123:102690.
    PubMed     Abstract available


    August 2021
  87. LEE AYS, Reed JH, Gordon TP
    Anti-Ro60 and anti-Ro52/TRIM21: Two distinct autoantibodies in systemic autoimmune diseases.
    J Autoimmun. 2021;124:102724.
    PubMed     Abstract available


  88. HIRSIGER JR, Tamborrini G, Harder D, Bantug GR, et al
    Chronic inflammation and extracellular matrix-specific autoimmunity following inadvertent periarticular influenza vaccination.
    J Autoimmun. 2021;124:102714.
    PubMed     Abstract available


  89. HEMED-SHAKED M, Cowman MK, Kim JR, Huang X, et al
    MTADV 5-MER peptide suppresses chronic inflammations as well as autoimmune pathologies and unveils a new potential target-Serum Amyloid A.
    J Autoimmun. 2021;124:102713.
    PubMed     Abstract available


  90. HANSEN RB, Simard JF, Faurschou M, Jacobsen S, et al
    Distinct patterns of comorbidity prior to diagnosis of incident systemic lupus erythematosus in the Danish population.
    J Autoimmun. 2021;123:102692.
    PubMed     Abstract available


  91. LU Q, Long H, Chow S, Hidayat S, et al
    Guideline for the diagnosis, treatment and long-term management of cutaneous lupus erythematosus.
    J Autoimmun. 2021;123:102707.
    PubMed     Abstract available


  92. RAJENDRAN S, Quesada-Masachs E, Zilberman S, Graef M, et al
    IL-17 is expressed on beta and alpha cells of donors with type 1 and type 2 diabetes.
    J Autoimmun. 2021;123:102708.
    PubMed     Abstract available


  93. ZHANG P, Zhang Y, Pan M, Liu Z, et al
    Proteomic analyses of plasma-derived exosomes in immunoglobulin (Ig) G4-related disease and their potential roles in B cell differentiation and tissue damage.
    J Autoimmun. 2021;122:102650.
    PubMed     Abstract available


    July 2021
  94. VUILLE-LESSARD E, Montani M, Bosch J, Semmo N, et al
    Autoimmune hepatitis triggered by SARS-CoV-2 vaccination.
    J Autoimmun. 2021;123:102710.
    PubMed     Abstract available


  95. ZHOU S, Li Q, Zhou S, Zhao M, et al
    A novel humanized cutaneous lupus erythematosus mouse model mediated by IL-21-induced age-associated B cells.
    J Autoimmun. 2021;123:102686.
    PubMed     Abstract available


  96. IBANEZ-VEGA J, Vilchez C, Jimenez K, Guevara C, et al
    Cellular and molecular regulation of the programmed death-1/programmed death ligand system and its role in multiple sclerosis and other autoimmune diseases.
    J Autoimmun. 2021;123:102702.
    PubMed     Abstract available


  97. BAKASIS AD, Mavragani CP, Boki KA, Tzioufas AG, et al
    COVID-19 infection among autoimmune rheumatic disease patients: Data from an observational study and literature review.
    J Autoimmun. 2021;123:102687.
    PubMed     Abstract available


  98. GHIELMETTI M, Schaufelberger HD, Mieli-Vergani G, Cerny A, et al
    Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: A novel clinical entity?
    J Autoimmun. 2021;123:102706.
    PubMed     Abstract available


  99. GRAVER JC, Abdulahad W, van der Geest KSM, Heeringa P, et al
    Association of the CXCL9-CXCR3 and CXCL13-CXCR5 axes with B-cell trafficking in giant cell arteritis and polymyalgia rheumatica.
    J Autoimmun. 2021;123:102684.
    PubMed     Abstract available


  100. REN HM, Lukacher AE, Rahman ZSM, Olsen NJ, et al
    New developments implicating IL-21 in autoimmune disease.
    J Autoimmun. 2021;122:102689.
    PubMed     Abstract available


  101. MCEACHERN E, Carroll AM, Fribourg M, Schiano TD, et al
    Corrigendum to "Erythropoietin administration expands regulatory T cells in patients with autoimmune hepatitis" [J. Autoimmun. 119C (2021) 102629].
    J Autoimmun. 2021;121:102665.
    PubMed    


  102. MCGONAGLE D, De Marco G, Bridgewood C
    Mechanisms of Immunothrombosis in Vaccine-Induced Thrombotic Thrombocytopenia (VITT) Compared to Natural SARS-CoV-2 Infection.
    J Autoimmun. 2021;121:102662.
    PubMed     Abstract available


  103. DOTAN A, Shoenfeld Y
    Perspectives on vaccine induced thrombotic thrombocytopenia.
    J Autoimmun. 2021;121:102663.
    PubMed     Abstract available


    June 2021
  104. MONSTED MO, Falck ND, Pedersen K, Buschard K, et al
    Intestinal permeability in type 1 diabetes: An updated comprehensive overview.
    J Autoimmun. 2021;122:102674.
    PubMed     Abstract available


  105. LINGEL H, Meltendorf S, Billing U, Thurm C, et al
    Unique autoantibody prevalence in long-term recovered SARS-CoV-2-infected individuals.
    J Autoimmun. 2021;122:102682.
    PubMed     Abstract available


  106. DIANA T, Ungerer M, Wuster C, Fassbender J, et al
    A cyclic peptide significantly improves thyroid function, thyrotropin-receptor antibodies and orbital mucine /collagen content in a long-term Graves' disease mouse model.
    J Autoimmun. 2021;122:102666.
    PubMed     Abstract available


  107. GU Y, Merriman C, Guo Z, Jia X, et al
    Novel autoantibodies to the beta-cell surface epitopes of ZnT8 in patients progressing to type-1 diabetes.
    J Autoimmun. 2021;122:102677.
    PubMed     Abstract available


  108. RODRIGUEZ-PEREZ AI, Labandeira CM, Pedrosa MA, Valenzuela R, et al
    Autoantibodies against ACE2 and angiotensin type-1 receptors increase severity of COVID-19.
    J Autoimmun. 2021;122:102683.
    PubMed     Abstract available


  109. KRILIS M, Qi M, Ioannou Y, Zhang JY, et al
    Clinical relevance of nitrated beta 2-glycoprotein I in antiphospholipid syndrome: Implications for thrombosis risk.
    J Autoimmun. 2021;122:102675.
    PubMed     Abstract available


  110. KJELDSEN J, Nielsen J, Ellingsen T, Knudsen T, et al
    Outcome of COVID-19 in hospitalized patients with chronic inflammatory diseases. A population based national register study in Denmark.
    J Autoimmun. 2021;120:102632.
    PubMed     Abstract available


  111. DE BRUYN CARLIER T, Badloe FMS, Ring J, Gutermuth J, et al
    Autoreactive T cells and their role in atopic dermatitis.
    J Autoimmun. 2021;120:102634.
    PubMed     Abstract available


    May 2021
  112. NISHIMURA T, Okayasu T, Hosoi H, Kitahara T, et al
    Long-term (16-26 years) follow-up outcome of steroid therapy in refractory autoimmune sensorineural hearing loss.
    J Autoimmun. 2021;121:102664.
    PubMed     Abstract available


  113. TAKESHITA M, Suzuki K, Nakazawa M, Kamata H, et al
    Antigen-driven autoantibody production in lungs of interstitial lung disease with autoimmune disease.
    J Autoimmun. 2021;121:102661.
    PubMed     Abstract available


  114. GRAHAM JJ, Longhi MS, Heneghan MA
    T helper cell immunity in pregnancy and influence on autoimmune disease progression.
    J Autoimmun. 2021;121:102651.
    PubMed     Abstract available


  115. GHESQUIERE T, Ciudad M, Ramon A, Greigert H, et al
    Mucosal-associated invariant T cells in Giant Cell Arteritis.
    J Autoimmun. 2021;121:102652.
    PubMed     Abstract available


  116. KIM JS, Kim IH, Byun JM, Chang JH, et al
    Population-based study on the association between autoimmune disease and lymphoma: National Health Insurance Service-National Sample Cohort 2002-2015 in Korea.
    J Autoimmun. 2021;121:102647.
    PubMed     Abstract available


  117. YANAOKA H, Nagafuchi Y, Hanata N, Takeshima Y, et al
    Identifying the most influential gene expression profile in distinguishing ANCA-associated vasculitis from healthy controls.
    J Autoimmun. 2021;119:102617.
    PubMed     Abstract available


  118. HEIKKILA N, Sormunen S, Mattila J, Harkonen T, et al
    Generation of self-reactive, shared T-cell receptor alpha chains in the human thymus.
    J Autoimmun. 2021;119:102616.
    PubMed     Abstract available


  119. THANOU A, Jupe E, Purushothaman M, Niewold TB, et al
    Clinical disease activity and flare in SLE: Current concepts and novel biomarkers.
    J Autoimmun. 2021;119:102615.
    PubMed     Abstract available


  120. HAMMINGER P, Marchetti L, Preglej T, Platzer R, et al
    Histone deacetylase 1 controls CD4(+) T cell trafficking in autoinflammatory diseases.
    J Autoimmun. 2021;119:102610.
    PubMed     Abstract available


    April 2021
  121. VALENTI L, Griffini S, Lamorte G, Grovetti E, et al
    Corrigendum to "Chromosome 3 cluster rs11385942 variant links complement activation with severe COVID-19" [J. Autoimmun. 117C (2020) 102595].
    J Autoimmun. 2021;120:102646.
    PubMed    


  122. WILHELM M, Bonam SR, Schall N, Bendorius M, et al
    Implication of a lysosomal antigen in the pathogenesis of lupus erythematosus.
    J Autoimmun. 2021;120:102633.
    PubMed     Abstract available


  123. WANG JY, Zhang W, Roehrl MW, Roehrl VB, et al
    An autoantigen profile of human A549 lung cells reveals viral and host etiologic molecular attributes of autoimmunity in COVID-19.
    J Autoimmun. 2021;120:102644.
    PubMed     Abstract available


  124. VAN WIGCHEREN GF, Roelofs D, Figdor CG, Florez-Grau G, et al
    Three distinct tolerogenic CD14(+) myeloid cell types to actively manage autoimmune disease: Opportunities and challenges.
    J Autoimmun. 2021;120:102645.
    PubMed     Abstract available


    March 2021
  125. HALPERT G, Watad A, Tsur AM, Dotan A, et al
    Autoimmune dysautonomia in women with silicone breast implants.
    J Autoimmun. 2021;120:102631.
    PubMed     Abstract available


  126. BENKAHLA MA, Sabouri S, Kiosses WB, Rajendran S, et al
    HLA class I hyper-expression unmasks beta cells but not alpha cells to the immune system in pre-diabetes.
    J Autoimmun. 2021;119:102628.
    PubMed     Abstract available


    February 2021
  127. BERGLIN E, Mohammad AJ, Dahlqvist J, Johansson L, et al
    Anti-neutrophil cytoplasmic antibodies predate symptom onset of ANCA-associated vasculitis. A case-control study.
    J Autoimmun. 2021;117:102579.
    PubMed     Abstract available


  128. GARIMELLA MG, He C, Chen G, Li QZ, et al
    The B cell response to both protein and nucleic acid antigens displayed on apoptotic cells are dependent on endosomal pattern recognition receptors.
    J Autoimmun. 2021;117:102582.
    PubMed     Abstract available


    January 2021
  129. PENG B, Temple BR, Yang J, Geng S, et al
    Identification of a primary antigenic target of epitope spreading in endemic pemphigus foliaceus.
    J Autoimmun. 2021;116:102561.
    PubMed     Abstract available


    September 2020
  130. LOMBARDI A, Concepcion E, Hou H, Arib H, et al
    Retro-inverso D-peptides as a novel targeted immunotherapy for Type 1 diabetes.
    J Autoimmun. 2020 Sep 17:102543. doi: 10.1016/j.jaut.2020.102543.
    PubMed     Abstract available


    December 2019
  131. SABOURI S, Benkahla MA, Kiosses WB, Rodriguez-Calvo T, et al
    Human herpesvirus-6 is present at higher levels in the pancreatic tissues of donors with type 1 diabetes.
    J Autoimmun. 2019 Dec 6:102378. doi: 10.1016/j.jaut.2019.102378.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: